| abstract |
The invention relates to pentafluorosulfanyl-benzoolguanidines of formulas (I) and (II), in which R1 to R4 have the meanings given in the claims. These pentafluorosulfanyl-benzoylguanidines are suitable as antiarrhythmic drugs with cardioprotective components for the prophylaxis or for the treatment of infarction and for the treatment of angina pectoris. They also preventively inhibit pathophysiological processes during the occurrence of ischemic injuries, especially in the occurrence of ischemic cardiac arrhythmias. |